The collaboration between Sanofi and Kymera Therapeutics on SAR444656 may represent a significant opportunity for competition ...

Nektar Therapeutics has completed target enrollment for its phase 2b study of rezpegaldesleukin for the treatment of patients ...

Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

The combination treatment specifically targets KRAS-mutated metastatic colorectal cancer (CRC) to improve progression-free ...

Elanco Animal Health Inc. (NYSE:ELAN), a leading player in the animal health industry with a market capitalization of $5.95 billion, has been navigating a complex landscape of product launches, ...

Out of more than 3,000 skin diseases, how do you know what condition you have? These 23 skin rash pictures and expert tips ...

The following is a summary of “Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients ...

Elanco Animal Health is making progress on debt repayment, new product approvals, and launches. Learn why ELAN stock is a Buy ...

Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.

Technoderma Medicines has completed its phase 2a trial of TDM-180935 for the treatment of atopic dermatitis, demonstrating ...

As we increase the number of patients, we remain excited by the outlook for our Phase 1 clinical trial of soquelitinib for ...